Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Consistent data collection makes protocol adjustments more informed and outcomes more meaningful
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Although vitamin B12 tablets are sold in large dosages well beyond the recommended dietary limit, these quantities do not guarantee that the total portion will be absorbed because sufficient amounts of intrinsic factors are also required
Lyophilized GHK-Cu powder should be stored at 20C protected from direct light for maximum stability up to 2 years under proper conditions
